We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Number crunching.
- Abstract
This year's meeting of the U.S. Biotechnology Industry Organization (BIO) held in Washington D.C. at the end of June 2003 was the largest biotechnology industry gabfest ever. According to BIO, 16,234 registrants and 1,268 exhibits crammed into 2.3 million square feet of space. Attendees included no less than one president of the U.S. Biotechnology is now a mature sector with large companies offering steady employment not only to scientists and entrepreneurs, but also clinical trial coordinators, regulatory professionals, reimbursement specialists, marketing/sales personnel, accounting/tax experts, consultants, PR agents and lawyers. But despite the overabundance of regional development agencies and delegations at BIO, the industry that launched a thousand companies is unlikely to be launching a thousand more anytime soon.
- Subjects
UNITED States; BIOTECHNOLOGY industries; HEALTH insurance reimbursement; ASSOCIATIONS, institutions, etc.
- Publication
Nature Biotechnology, 2003, Vol 21, Issue 8, p831
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0803-831b